Ferey Faridian

Founded by James Montgomery in 1986, Montgomery & Co. LLC, formerly Digital Coast Partners LLC, is an investment banking firm and broker/dealer headquartered in Santa Monica, California with an additional office in San Francisco. The firm provides a broad range of services including mergers & acquisitions, private placements and strategic advisory services. Montgomery & Co. is a member of the NASD and the SIPC. They focus on growth companies in the software, healthcare and media sectors. Within the software sector, the firm focuses on: (1) enterprise software (2) infrastructure software (3) vertical applications including healthcare information technology and human capital management and (4) business intelligence. Montgomery & Co.'s interests within the healthcare sector include: (1) information technology security (2) wireless (3) IP infrastructure and services (4) semiconductors/enterprise hardware (5) technology-enabled services (6) biotechnology (7) healthcare services (8) consumer healthcare (9) specialty pharmaceuticals (10) medical devices (11) tools and equipment and (12) reagents. Within the media sector, the firm focuses on: (1) advertising and marketing services (2) digital media services (3) entertainment, content and distribution (4) mobile media and (5) online services.

BV-Cornerstone Ventures LP is a venture capital firm located in Broomfield, Colorado with an additional office in McLean, Virginia

Intelligent Fiber Optic Systems, Inc. develops, manufactures, and distributes sensors, optical interrogators, user interfaces, and optical components. The private company is based in Santa Clara, CA and has subsidiaries in the United States.

LARTA Institute is a non-profit organization based in Los Angeles, CA that aims to foster science and technology innovation for a sustainable planet. LARTA Institute's innovation platform and ecosystem accelerate new science and technology from idea to sustainable enterprise by providing a unique combination of connections, resources, and funding. The organization has helped over 4,500 startups, and its alumni have raised more than $7 billion in external funding. LARTA Institute offers startup programs designed to accelerate the translation of new ideas into sustainable enterprises and is committed to supporting diverse startup founders. The organization was founded in 1993 as a regional technology alliance to stimulate economic development of technology-based enterprises and has since become a national partner for numerous federal government agencies.

Newport LLC provides legal services. Kevin Poole has been the CEO of the American company since 2012.

Entefy, Inc. provides communication and digital interaction solutions. It specializes in artificial intelligence, digital communication, mobile, internet of things, big data, search, privacy, security, software, machine learning, computer vision and natural language processing. The company was founded by Alston Ghafourifar and Brienne Ghafourifar and is headquartered in Palo Alto, CA.

SynTouch, Inc. develops and produces sensor technology that endows robots with the ability to replicate human sense of touch. It specializes in measure haptic, correlate to perception and human preferences. The company was founded by Gerald Loeb, Matt Borzage, Peng Zhang and Jeremy Fishel in 2008 and is headquartered in Montrose, CA.

RadioMedix, Inc. is a clinical stage biotechnology company based in Houston, TX, focused on innovative targeted radiopharmaceuticals for diagnosis, monitoring, and therapy of cancer. The private company commercializes radiopharmaceuticals for PET imaging and targeted alpha and beta-emitter therapy. The company covers the entire value chain from drug discovery to sponsoring and conducting clinical trials. The company has established contract service facilities for academic and industrial partners, including a drug discovery center, pre-clinical core facility, and a CGMP manufacturing and analytical suite for human clinical trials and commercial phase manufacturing of the radiopharmaceuticals. The company has also established a large-scale post-approval commercial manufacturing facility known as the Spica Center. The company's pipeline includes Detectnet™, a diagnostic agent for management of somatostatin expressing neuroendocrine cancers using PET/CT technology. The company was founded by Ebrahim S. Delpassand and he has been the CEO since incorporation.